Related Experiment Video
Updated: Jun 19, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia
Insights
Schizophrenia patients show altered blood plasma levels of three key ceramide species, particularly Cer(d18:1/18:0). These findings suggest shared metabolic abnormalities link schizophrenia and cardiovascular disease.
Area of Science:
- Biochemistry
- Psychiatry
- Cardiology
Background:
- Schizophrenia is linked to cardiovascular disease, a leading cause of mortality in patients.
- Shared genetic factors suggest underlying metabolic abnormalities.
- Specific blood plasma ceramides are implicated in cardiovascular disease risk.
Purpose of the Study:
- To compare blood plasma levels of three ceramide species (Cer(d18:1/16:0), Cer(d18:1/18:0), and Cer(d18:1/24:1)) between schizophrenia patients and healthy controls.
Main Methods:
- Quantified three specific ceramide species in blood plasma from 82 schizophrenia patients and 138 controls.
- Validated findings in an independent cohort including first-episode psychosis patients.
Main Results:
- All three measured ceramide species showed significant alterations in schizophrenia patients compared to controls.
- Cer(d18:1/18:0) exhibited the most pronounced concentration difference.
Conclusions:
- Altered levels of these ceramides may indicate common metabolic pathways in schizophrenia and cardiovascular disease.
- Ceramide profiling could offer insights into shared pathophysiology and potential biomarkers.
Introduction:
Schizophrenia, although a debilitating mental illness, greatly affects individuals' physical health as well. One of the leading somatic comorbidities associated with schizophrenia is cardiovascular disease, which has been estimated to be one of the leading causes of excess mortality in patients diagnosed with schizophrenia. Although the shared susceptibility to schizophrenia and cardiovascular disease is well established, the mechanisms linking these two disorders are not well understood. Genetic studies have hinted toward shared lipid metabolism abnormalities co-occurring in the two disorders, while lipid compounds have emerged as prognostic markers for cardiovascular disease. In particular, three ceramide species in the blood plasma, Cer(d18:1/16:0), Cer(d18:1/18:0), and Cer(d18:1/24:1), have been robustly linked to the latter disorder.
Aim:
We aimed to assess the differences in abundances of Cer(d18:1/16:0), Cer(d18:1/18:0), and Cer(d18:1/24:1) in the blood plasma of schizophrenia patients compared to healthy controls.
Methods:
We measured the abundances of Cer(d18:1/16:0), Cer(d18:1/18:0), and Cer(d18:1/24:1) in a cohort of 82 patients with schizophrenia and 138 controls without a psychiatric diagnosis and validated the results using an independent cohort of 26 patients with schizophrenia, 55 control individuals, and 19 patients experiencing a first psychotic episode.
Results:
We found significant alterations for all three ceramide species Cer(d18:1/16:0), Cer(d18:1/18:0), and Cer(d18:1/24:1) and a particularly strong difference in concentrations between psychiatric patients and controls for the ceramide species Cer(d18:1/18:0).
Conclusions:
The alteration of Cer(d18:1/16:0), Cer(d18:1/18:0), and Cer(d18:1/24:1) levels in the blood plasma might be a manifestation of metabolic abnormalities common to both schizophrenia and cardiovascular disease.
Related Concept Videos
Assembly of the Lipid Bilayer in the ER
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Asymmetric Lipid Bilayer

